DexCom (Germany) Today
| DC4 Stock | EUR 69.66 0.62 0.88% |
Performance4 of 100
| Odds Of DistressLess than 9
|
DexCom is trading at 69.66 as of the 25th of November 2024. This is a 0.88 percent decrease since the beginning of the trading day. The stock's lowest day price was 69.66. DexCom has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for DexCom Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. The company has 386.41 M outstanding shares. More on DexCom Inc
Moving against DexCom Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DexCom Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DexCom's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DexCom or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
DexCom Inc (DC4) is traded on Frankfurt Exchange in Germany and employs 7,500 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 40.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DexCom's market, we take the total number of its shares issued and multiply it by DexCom's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DexCom Inc classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 386.41 M outstanding shares.
DexCom Inc has accumulated about 1.38 B in cash with 669.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.11.
Check DexCom Probability Of Bankruptcy
Ownership AllocationDexCom Inc retains a total of 386.41 Million outstanding shares. The majority of DexCom Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in DexCom Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in DexCom. Please pay attention to any change in the institutional holdings of DexCom Inc as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check DexCom Ownership Details
DexCom Inc Risk Profiles
Although DexCom's alpha and beta are two of the key measurements used to evaluate DexCom's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.44 | |||
| Standard Deviation | 2.02 | |||
| Variance | 4.07 |
DexCom Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DexCom without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
DexCom Corporate Management
Elected by the shareholders, the DexCom's board of directors comprises two types of representatives: DexCom inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DexCom. The board's role is to monitor DexCom's management team and ensure that shareholders' interests are well served. DexCom's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DexCom's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Sayer | CEO Chairman | Profile | |
| Matthew Dolan | Corp Strategy | Profile | |
| Michael Brown | Ex Officer | Profile | |
| Jacob Leach | Ex COO | Profile | |
| Sadie Stern | Ex Officer | Profile | |
| Jereme Sylvain | CFO VP | Profile | |
| Sean Christensen | Director Relations | Profile |
Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.